Clinical Trials Directory

Trials / Completed

CompletedNCT04690205

Hospital at Home at EOL in Heme Malignancies

Hospital-at-Home Care Model to Optimize End-of-Life (EOL) Care for Patients With Hematologic Malignancies: A Pilot Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is evaluating an intervention, which the investigators call "Optimize End of Life (EOL) Care at Home," that entails remote patient monitoring and home-based supportive care for patients with advanced hematologic malignancies.

Detailed description

This research study is a single arm pilot feasibility study, which is the first-time investigators are examining this care at home intervention in patients with advanced hematologic malignancies. The research study procedures include screening for eligibility, questionnaires, remote patient monitoring (e.g. patient-reported symptoms, home monitored vital signs) and hospital care at home (e.g. providing maximal supportive care to to address and manage patients' symptoms) and structured communications oncology clinicians to optimize end of life care for patients with advanced hematologic malignancies. Participants will include 3 groups: 1\) Enrolled patients with advanced hematologic malignancies receiving the end of life (EOL) care at home intervention; 2) caregivers of these patients; and 3) oncology clinicians caring for these patients. Participants will be in this research study for approximately six months after consent. It is expected that about 30 patients, 30 caregivers, and 15 oncology clinicians will take part in this research study. Medically Home company is supporting this research study by providing funding.

Conditions

Interventions

TypeNameDescription
OTHEREnd of Life (EOL) Care at at HomeRemote monitoring and home-based care designed for patients with advanced hematologic malignancies

Timeline

Start date
2021-02-26
Primary completion
2024-07-01
Completion
2025-07-01
First posted
2020-12-30
Last updated
2025-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04690205. Inclusion in this directory is not an endorsement.